George Mavrothalassitis

4PUBLICATIONS
6CO-AUTHORS
Molecular targetsCraniofacial biologyEpigenetics (incl. genome methylation and epigenomics)Biological control
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 12, 2024
Heterozygous variants disrupting the interaction of ERF with activated ERK1/2 cause microcephaly, developmental delay, and skeletal anomalies.

Lucia Micale, Aikaterini Vourlia, Carmela Fusco

|Mar 14, 2019
Craniofacial, orofacial and dental disorders: the role of the RAS/ERK pathway.

Angeliki Vogiatzi, George Mavrothalassitis

|Jul 12, 2017
The Ets2 Repressor Factor (Erf) Is Required for Effective Primitive and Definitive Hematopoiesis.

Ioanna Peraki, James Palis, George Mavrothalassitis

|Mar 01, 2017
Suppression of Fgf2 by ETS2 repressor factor (ERF) is required for chorionic trophoblast differentiation.

Elena Vorgia, Andreas Zaragkoulias, Ioanna Peraki

Pageof 1